Application of Eryngiolide A in anti-platelet aggregation medicines
An anti-platelet aggregation and drug technology, which is applied in the direction of drug combination, medical preparations containing active ingredients, blood diseases, etc., can solve urgent and minor adverse reactions and other problems
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0011] Embodiment 1: Preparation of the compound Eryngiolide A tablet involved in the present invention:
[0012] Take 20 grams of compound Eryngiolide A, add 180 grams of conventional excipients for tablet preparation, mix well, and make 1000 tablets with a conventional tabletting machine.
Embodiment 2
[0013] Embodiment 2: the preparation of the compound Eryngiolide A capsule of the present invention:
[0014] Get 20 grams of compound Eryngiolide A, add conventional auxiliary materials for preparing capsules such as 180 grams of starch, mix well, and pack into capsules to make 1000 tablets.
[0015] The following pharmacodynamic experiments will further illustrate its drug activity.
[0016] The following examples illustrate the invention in more detail without limiting it in any way.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


